FindTrial
Sign In

Use of Amma Magaperu Sanjeevi Pettagam during pregnancy and lactation for maintaining health

Evaluation of Effectiveness of Amma Magaperu Sanjeevi Pettagam during Pregnancy and Lactating period - EEAMSPPL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/030003
Enrollment
200
Registered
2020-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: AMMA MAGAPERU SANJEEVI PETTAGAM: It is taken during pregnancy and lactation Frequency and dosage First Trimester 1.Karuvepillai podi - 1 tspn twice a day after food with buttermilk.

Sponsors

Central Council for Research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Pregnant mothers who are using Amma Magaperu Sanjeevi Pettagam

Exclusion criteria

Exclusion criteria: Diabetes Mellitus Hypertension

Design outcomes

Primary

MeasureTime frame
Anemic condition of mother Mode of delivery Birthweight of child and general health of childTimepoint: Baseline data from 1st trimester Hb at the time of delivery and during the 6 months of lactating period Outcome at the time of delivery and during 6 months of lactating period—

Secondary

MeasureTime frame
Anemic condition of mother Mode of delivery Birthweight of child and general health of motherTimepoint: Baseline data from 1st trimester Hb at the time of delivery and during the 6 months of lactating period Outcome at the time of delivery and during 6 months of lactating period—

Countries

India

Contacts

Public ContactProf Dr R S Ramaswamy

RVS Siddha Medical College and Hospital

haripriyaadv1999@gmail.com7867935446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026